A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients (vol 47, pg 986, 2010)

被引：0
|
作者：
Virchow, J. Christian
机构：
来源：
JOURNAL OF ASTHMA | 2011年 / 48卷 / 06期
关键词：
D O I：
10.3109/02770903.2011.589639
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：650 / 652
页数：3
相关论文
共 50 条
  • [31] Results from a 12-month open-label safety study of lumateperone (ITI-007) in patients with stable symptoms of schizophrenia
    Correll, C. U.
    Vanover, K. E.
    Durgam, S.
    Weingart, M.
    Davis, R.
    Satlin, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S455 - S456
  • [32] A multicentre open label study of the use of levetiracetam as add-on treatment in patients with epilepsy and intellectual disabilities
    Kerr, Mike
    Beavis, J.
    Felce, D.
    Meek, A.
    EPILEPSIA, 2007, 48 : 319 - 320
  • [33] Long-term add-on pregabalin treatment of patients with partial seizures: An analysis of four open-label trials
    Uthman, B
    Lee, C
    Fukui, A
    Spiegel, K
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S145 - S145
  • [34] ADD-ON OMALIZUMAB IN PERSISTENT DIFFICULT-TO-TREAT ASTHMA: A 12-MONTH STUDY ON CLINICAL, ECONOMIC OUTCOMES AND RELATED COST/UTILITY
    Dal Negro, R. W.
    Pradelli, L.
    Micheletto, C.
    Tognella, S.
    Iannazzo, S.
    VALUE IN HEALTH, 2009, 12 (07) : A303 - A304
  • [35] Comparative 12-month retention rate, effectiveness and tolerability of perampanel when used as a first add-on or a late add-on treatment in patients with focal epilepsies: The COM-PER study
    Canas, Nuno
    Felix, Catarina
    Silva, Vanessa
    Arraiolos, Ana
    Fernandez-Llimos, Fernando
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2021, 86 : 109 - 115
  • [36] A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults
    Richards, Cynthia
    Iosifescu, Dan V.
    Mago, Rajnish
    Sarkis, Elias
    Geibel, Brooke
    Dauphin, Matthew
    McIntyre, Roger S.
    Weisler, Richard
    Brawman-Mintzer, Olga
    Gu, Joan
    Madhoo, Manisha
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 336 - 343
  • [37] Adjunct modafinil improves excessive sleepiness in obstructive sleep apnea: A 12-month open-label extension study
    Williams, A
    THORAX, 2003, 58 : 7 - 7
  • [38] Safety and Effectiveness of Dasotraline in Binge-Eating Disorder: Results of an Open-Label, 12-Month Extension Study
    Mattingly, Greg
    Tsai, Joyce
    Kent, Justine
    Deng, Ling
    Goldman, Robert
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 113 - 113
  • [39] Safety and efficacy of long-term treatment with transdermal rotigotine in patients with idiopathic restless legs syndrome: A 12-month open-label extension study
    Benes, H.
    Garcia-Borreguero, H.
    Oertel, W.
    Fichtner, A.
    Schollmayer, E.
    Trenkwalder, C.
    MOVEMENT DISORDERS, 2010, 25 (07) : S515 - S515
  • [40] Asenapine add-on treatment for schizophrenia adults who received antipsychotics: A 52-week, open-label study
    Kishi, Taro
    Iwama, Yasuhiro
    Sasagawa, Yuji
    Hiraoka, Shuichi
    Kamei, Aya
    Iwata, Nakao
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2023, 77 (06) : 365 - 366
12345